UFT, an anticancer agent that is composed of tegafur ( FT) and uracil at a molar ratio of 1: 4, is widely used in clinical practice in Japan to treat cancer patients requiring a long - term chemotherapy, and it is associated with few side effects, if any.	"UFT	0	3	Chemical"	"anticancer	8	18	Cancer"	"tegafur	45	52	Chemical"	"FT	55	57	Chemical"	"uracil	63	69	Chemical"	"cancer	150	156	Cancer"	"patients	157	165	Organism"	"[{""token"": ""UFT"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical""}, {""token"": ""anticancer"", ""start_span"": 8, ""end_span"": 18, ""type"": ""Cancer""}, {""token"": ""tegafur"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Chemical""}, {""token"": ""FT"", ""start_span"": 55, ""end_span"": 57, ""type"": ""Chemical""}, {""token"": ""uracil"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Chemical""}, {""token"": ""cancer"", ""start_span"": 150, ""end_span"": 156, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 157, ""end_span"": 165, ""type"": ""Organism""}]"
It was suggested that UFT has a stronger angiogenesis - inhibitory effect than did other fluorinated pyrimidines, partly due to its pharmacokinetic properties characterized by maintaining of higher and long - lasting blood levels of 5 - FU and partly due the inhibitory effects derived from gamma - hydroxybutyric acid and gamma - butyrolactone, UFT - specific metabolites.	"UFT	22	25	Chemical"	"fluorinated pyrimidines	89	112	Chemical"	"blood	217	222	Organism_substance"	"5 - FU	233	239	Chemical"	"gamma - hydroxybutyric acid	291	318	Chemical"	"gamma - butyrolactone	323	344	Chemical"	"UFT	346	349	Chemical"	"[{""token"": ""UFT"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""fluorinated pyrimidines"", ""start_span"": 89, ""end_span"": 112, ""type"": ""Chemical""}, {""token"": ""blood"", ""start_span"": 217, ""end_span"": 222, ""type"": ""Organism_substance""}, {""token"": ""5 - FU"", ""start_span"": 233, ""end_span"": 239, ""type"": ""Chemical""}, {""token"": ""gamma - hydroxybutyric acid"", ""start_span"": 291, ""end_span"": 318, ""type"": ""Chemical""}, {""token"": ""gamma - butyrolactone"", ""start_span"": 323, ""end_span"": 344, ""type"": ""Chemical""}, {""token"": ""UFT"", ""start_span"": 346, ""end_span"": 349, ""type"": ""Chemical""}]"
Formation of apoptotic bodies was preceded by lowering of intracellular polyamines, particularly putrescine, and both dose - and time - dependent inhibitory and activation effect by ACA on ornithine decarboxylase ( ODC) and spermidine / spermine N ( 1) - acetyltransferase ( SSAT), respectively.	"apoptotic bodies	13	29	Cellular_component"	"intracellular	58	71	Immaterial_anatomical_entity"	"putrescine	97	107	Chemical"	"ACA	182	185	Chemical"	"ornithine decarboxylase	189	212	Gene_or_gene_product"	"ODC	215	218	Gene_or_gene_product"	"SSAT	275	279	Gene_or_gene_product"	"[{""token"": ""apoptotic bodies"", ""start_span"": 13, ""end_span"": 29, ""type"": ""Cellular_component""}, {""token"": ""intracellular"", ""start_span"": 58, ""end_span"": 71, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""putrescine"", ""start_span"": 97, ""end_span"": 107, ""type"": ""Chemical""}, {""token"": ""ACA"", ""start_span"": 182, ""end_span"": 185, ""type"": ""Chemical""}, {""token"": ""ornithine decarboxylase"", ""start_span"": 189, ""end_span"": 212, ""type"": ""Gene_or_gene_product""}, {""token"": ""ODC"", ""start_span"": 215, ""end_span"": 218, ""type"": ""Gene_or_gene_product""}, {""token"": ""SSAT"", ""start_span"": 275, ""end_span"": 279, ""type"": ""Gene_or_gene_product""}]"
The effect of von Hippel - Lindau ( VHL) gene and hypoxia on VEGF - B and VEGF - C expression in the renal carcinoma cell line 786 - 0 transfected with wild - type and mutant VHL was determined by growing cells under 21% O2 - and 0. 1% O2.	"von Hippel - Lindau	14	33	Gene_or_gene_product"	"VHL	36	39	Gene_or_gene_product"	"VEGF - B	61	69	Gene_or_gene_product"	"VEGF - C	74	82	Gene_or_gene_product"	"renal carcinoma cell line 786 - 0	101	134	Cell"	"VHL	175	178	Gene_or_gene_product"	"cells	205	210	Cell"	"[{""token"": ""von Hippel - Lindau"", ""start_span"": 14, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""VHL"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - B"", ""start_span"": 61, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""renal carcinoma cell line 786 - 0"", ""start_span"": 101, ""end_span"": 134, ""type"": ""Cell""}, {""token"": ""VHL"", ""start_span"": 175, ""end_span"": 178, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 205, ""end_span"": 210, ""type"": ""Cell""}]"
Vascular abnormalities in the retina were compared between patients with vascularized ( n = 34, group 1) and nonvascularized ( n = 7, group 2) PED on indocyanine green angiography and correlated with the size of the PED and the presence of serous retinal detachment.	"Vascular	0	8	Multi"	"retina	30	36	Multi"	"patients	59	67	Organism"	"PED	143	146	Pathological_formation"	"indocyanine green	150	167	Chemical"	"PED	216	219	Pathological_formation"	"serous retinal	240	254	Multi"	"[{""token"": ""Vascular"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Multi""}, {""token"": ""retina"", ""start_span"": 30, ""end_span"": 36, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 59, ""end_span"": 67, ""type"": ""Organism""}, {""token"": ""PED"", ""start_span"": 143, ""end_span"": 146, ""type"": ""Pathological_formation""}, {""token"": ""indocyanine green"", ""start_span"": 150, ""end_span"": 167, ""type"": ""Chemical""}, {""token"": ""PED"", ""start_span"": 216, ""end_span"": 219, ""type"": ""Pathological_formation""}, {""token"": ""serous retinal"", ""start_span"": 240, ""end_span"": 254, ""type"": ""Multi""}]"
Blocking the activation of p44 / 42 mitogen - activated protein kinase ( MAPK) by the specific mitogen - induced extracellular kinase ( MEK) inhibitor, U0126, impaired modestly the ability of FVIIa to promote cell survival.	"p44 / 42 mitogen - activated protein kinase	27	70	Gene_or_gene_product"	"MAPK	73	77	Gene_or_gene_product"	"mitogen - induced extracellular kinase	95	133	Gene_or_gene_product"	"MEK	136	139	Gene_or_gene_product"	"U0126	152	157	Chemical"	"FVIIa	192	197	Gene_or_gene_product"	"cell	209	213	Cell"	"[{""token"": ""p44 / 42 mitogen - activated protein kinase"", ""start_span"": 27, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAPK"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitogen - induced extracellular kinase"", ""start_span"": 95, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""MEK"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""U0126"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Chemical""}, {""token"": ""FVIIa"", ""start_span"": 192, ""end_span"": 197, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 209, ""end_span"": 213, ""type"": ""Cell""}]"
CONCLUSION: Not only tumor cells but also TAMs secrete the VEGF - C in OSCC, and TAMs may play a major role in peritumoral lymphatic neoangiogenesis and lymphatic metastasis.	"tumor cells	21	32	Cell"	"TAMs	42	46	Cell"	"VEGF - C	59	67	Gene_or_gene_product"	"OSCC	71	75	Cancer"	"TAMs	81	85	Cell"	"peritumoral lymphatic	111	132	Multi"	"lymphatic	153	162	Organ"	"[{""token"": ""tumor cells"", ""start_span"": 21, ""end_span"": 32, ""type"": ""Cell""}, {""token"": ""TAMs"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""VEGF - C"", ""start_span"": 59, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""OSCC"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Cancer""}, {""token"": ""TAMs"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""peritumoral lymphatic"", ""start_span"": 111, ""end_span"": 132, ""type"": ""Multi""}, {""token"": ""lymphatic"", ""start_span"": 153, ""end_span"": 162, ""type"": ""Organ""}]"
We used a series of cell clones from a human teratocarcinoma cell line, PA - 1, to study the effect of transformation by an activated N - ras oncogene on the expression of genes involved in retinoic acid ( RA) - induced differentiation and growth regulation.	"cell clones	20	31	Cell"	"human	39	44	Organism"	"teratocarcinoma cell line	45	70	Cell"	"PA - 1	72	78	Cell"	"N - ras	134	141	Gene_or_gene_product"	"retinoic acid	190	203	Chemical"	"RA	206	208	Chemical"	"[{""token"": ""cell clones"", ""start_span"": 20, ""end_span"": 31, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Organism""}, {""token"": ""teratocarcinoma cell line"", ""start_span"": 45, ""end_span"": 70, ""type"": ""Cell""}, {""token"": ""PA - 1"", ""start_span"": 72, ""end_span"": 78, ""type"": ""Cell""}, {""token"": ""N - ras"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""retinoic acid"", ""start_span"": 190, ""end_span"": 203, ""type"": ""Chemical""}, {""token"": ""RA"", ""start_span"": 206, ""end_span"": 208, ""type"": ""Chemical""}]"
These observations provide evidence that enhanced proliferation in N - ras - transformed cells compromises teratocarcinoma cell differentiation by a mechanism that transiently suppresses homeobox gene induction and implies a central role for homeobox genes in RA - induced cell differentiation.	"N - ras	67	74	Gene_or_gene_product"	"cells	89	94	Cell"	"teratocarcinoma cell	107	127	Cell"	"homeobox	187	195	Gene_or_gene_product"	"homeobox	242	250	Gene_or_gene_product"	"RA	260	262	Chemical"	"cell	273	277	Cell"	"[{""token"": ""N - ras"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 89, ""end_span"": 94, ""type"": ""Cell""}, {""token"": ""teratocarcinoma cell"", ""start_span"": 107, ""end_span"": 127, ""type"": ""Cell""}, {""token"": ""homeobox"", ""start_span"": 187, ""end_span"": 195, ""type"": ""Gene_or_gene_product""}, {""token"": ""homeobox"", ""start_span"": 242, ""end_span"": 250, ""type"": ""Gene_or_gene_product""}, {""token"": ""RA"", ""start_span"": 260, ""end_span"": 262, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 273, ""end_span"": 277, ""type"": ""Cell""}]"
Furthermore, Ang II stimulated sFlt - 1 production in a dose - and time - dependent manner from human villous explants and cultured trophoblasts but not from endothelial cells, suggesting that trophoblasts are the primary source of sFlt - 1 during pregnancy.	"Ang II	13	19	Gene_or_gene_product"	"sFlt - 1	31	39	Gene_or_gene_product"	"human	96	101	Organism"	"trophoblasts	132	144	Cell"	"endothelial cells	158	175	Cell"	"trophoblasts	193	205	Cell"	"sFlt - 1	232	240	Gene_or_gene_product"	"[{""token"": ""Ang II"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""sFlt - 1"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Organism""}, {""token"": ""trophoblasts"", ""start_span"": 132, ""end_span"": 144, ""type"": ""Cell""}, {""token"": ""endothelial cells"", ""start_span"": 158, ""end_span"": 175, ""type"": ""Cell""}, {""token"": ""trophoblasts"", ""start_span"": 193, ""end_span"": 205, ""type"": ""Cell""}, {""token"": ""sFlt - 1"", ""start_span"": 232, ""end_span"": 240, ""type"": ""Gene_or_gene_product""}]"
These findings reveal a previously unrecognized regulatory role for Ang II on sFlt - 1 expression in murine and human pregnancy and suggest that elevated sFlt - 1 levels in preeclampsia may be caused by a dysregulation of the local renin / angiotensin system.	"Ang II	68	74	Gene_or_gene_product"	"sFlt - 1	78	86	Gene_or_gene_product"	"murine	101	107	Organism"	"human	112	117	Organism"	"sFlt - 1	154	162	Gene_or_gene_product"	"renin	232	237	Gene_or_gene_product"	"angiotensin	240	251	Gene_or_gene_product"	"[{""token"": ""Ang II"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""sFlt - 1"", ""start_span"": 78, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""murine"", ""start_span"": 101, ""end_span"": 107, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Organism""}, {""token"": ""sFlt - 1"", ""start_span"": 154, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}, {""token"": ""renin"", ""start_span"": 232, ""end_span"": 237, ""type"": ""Gene_or_gene_product""}, {""token"": ""angiotensin"", ""start_span"": 240, ""end_span"": 251, ""type"": ""Gene_or_gene_product""}]"
Ectopic decorin expression up - regulates VEGF expression in mouse cerebral endothelial cells via activation of the transcription factors Sp1, HIF1alpha, and Stat3.	"decorin	8	15	Gene_or_gene_product"	"VEGF	42	46	Gene_or_gene_product"	"mouse	61	66	Organism"	"cerebral endothelial cells	67	93	Cell"	"Sp1	138	141	Gene_or_gene_product"	"HIF1alpha	143	152	Gene_or_gene_product"	"Stat3	158	163	Gene_or_gene_product"	"[{""token"": ""decorin"", ""start_span"": 8, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Organism""}, {""token"": ""cerebral endothelial cells"", ""start_span"": 67, ""end_span"": 93, ""type"": ""Cell""}, {""token"": ""Sp1"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF1alpha"", ""start_span"": 143, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""Stat3"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Gene_or_gene_product""}]"
"Correlation between D2 - 40 + LVI and menopausal - status, HER2 - status and histological type was not significant, while there was a significant correlation of D2 - 40 and so called "" triple negative "" tumors ( ER / PR and HER2neu - negative)."	"D2 - 40	20	27	Gene_or_gene_product"	"HER2	59	63	Gene_or_gene_product"	"D2 - 40	161	168	Gene_or_gene_product"	"tumors	203	209	Cancer"	"ER	212	214	Gene_or_gene_product"	"PR	217	219	Gene_or_gene_product"	"HER2neu	224	231	Gene_or_gene_product"	"[{""token"": ""D2 - 40"", ""start_span"": 20, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""HER2"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""D2 - 40"", ""start_span"": 161, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 203, ""end_span"": 209, ""type"": ""Cancer""}, {""token"": ""ER"", ""start_span"": 212, ""end_span"": 214, ""type"": ""Gene_or_gene_product""}, {""token"": ""PR"", ""start_span"": 217, ""end_span"": 219, ""type"": ""Gene_or_gene_product""}, {""token"": ""HER2neu"", ""start_span"": 224, ""end_span"": 231, ""type"": ""Gene_or_gene_product""}]"
In human endothelial cells, cediranib inhibited VEGF - E - induced phosphorylation of VEGFR - 2 and VEGF - C156S - induced phosphorylation of VEGFR - 3 at concentrations of less than / = 1nmol / L and inhibited activation of downstream signaling molecules.	"human	3	8	Organism"	"endothelial cells	9	26	Cell"	"cediranib	28	37	Chemical"	"VEGF - E	48	56	Gene_or_gene_product"	"VEGFR - 2	86	95	Gene_or_gene_product"	"VEGF - C156S	100	112	Gene_or_gene_product"	"VEGFR - 3	142	151	Gene_or_gene_product"	"[{""token"": ""human"", ""start_span"": 3, ""end_span"": 8, ""type"": ""Organism""}, {""token"": ""endothelial cells"", ""start_span"": 9, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""cediranib"", ""start_span"": 28, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""VEGF - E"", ""start_span"": 48, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 2"", ""start_span"": 86, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C156S"", ""start_span"": 100, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 3"", ""start_span"": 142, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}]"
Consistent with the decrease in lymph node metastasis, tumor lymphangiogenesis and expression of vascular endothelial growth factor C ( VEGF - C) was significantly decreased in artemisinin - treated mice, as compared to control mice.	"lymph node	32	42	Multi"	"tumor	55	60	Cancer"	"vascular endothelial growth factor C	97	133	Gene_or_gene_product"	"VEGF - C	136	144	Gene_or_gene_product"	"artemisinin	177	188	Chemical"	"mice	199	203	Organism"	"mice	228	232	Organism"	"[{""token"": ""lymph node"", ""start_span"": 32, ""end_span"": 42, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Cancer""}, {""token"": ""vascular endothelial growth factor C"", ""start_span"": 97, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 136, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}, {""token"": ""artemisinin"", ""start_span"": 177, ""end_span"": 188, ""type"": ""Chemical""}, {""token"": ""mice"", ""start_span"": 199, ""end_span"": 203, ""type"": ""Organism""}, {""token"": ""mice"", ""start_span"": 228, ""end_span"": 232, ""type"": ""Organism""}]"
Antibodies developed to human endosialin were used to investigate endosialin expression and function in human prenatal brain pericytes and pericytes residing in tumors.	"human	24	29	Organism"	"endosialin	30	40	Gene_or_gene_product"	"endosialin	66	76	Gene_or_gene_product"	"human	104	109	Organism"	"prenatal brain pericytes	110	134	Cell"	"pericytes	139	148	Cell"	"tumors	161	167	Cancer"	"[{""token"": ""human"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Organism""}, {""token"": ""endosialin"", ""start_span"": 30, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""endosialin"", ""start_span"": 66, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Organism""}, {""token"": ""prenatal brain pericytes"", ""start_span"": 110, ""end_span"": 134, ""type"": ""Cell""}, {""token"": ""pericytes"", ""start_span"": 139, ""end_span"": 148, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 161, ""end_span"": 167, ""type"": ""Cancer""}]"
The Interferon - inducible gene IFI16, a member of the HIN200 family, is activated by oxidative stress and cell density, in addition to Interferons, and it is implicated in the regulation of endothelial cell proliferation and vessel formation in vitro.	"Interferon	4	14	Gene_or_gene_product"	"IFI16	32	37	Gene_or_gene_product"	"HIN200	55	61	Gene_or_gene_product"	"cell	107	111	Cell"	"Interferons	136	147	Gene_or_gene_product"	"endothelial cell	191	207	Cell"	"vessel	226	232	Multi"	"[{""token"": ""Interferon"", ""start_span"": 4, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""IFI16"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIN200"", ""start_span"": 55, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Cell""}, {""token"": ""Interferons"", ""start_span"": 136, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 191, ""end_span"": 207, ""type"": ""Cell""}, {""token"": ""vessel"", ""start_span"": 226, ""end_span"": 232, ""type"": ""Multi""}]"
To examine whether IFI16 induction might be extended to other proinflammatory cytokines such as tumor necrosis factor ( TNF) - alpha, we used the strategy of the RNA interference to knock down IFI16 expression, and analyze the capability of TNF - alpha to stimulate intercellular adhesion molecule - 1 ( ICAM - 1 or CD54) expression in the absence of functional IFI16.	"IFI16	19	24	Gene_or_gene_product"	"IFI16	193	198	Gene_or_gene_product"	"TNF - alpha	241	252	Gene_or_gene_product"	"intercellular adhesion molecule - 1	266	301	Gene_or_gene_product"	"ICAM - 1	304	312	Gene_or_gene_product"	"CD54	316	320	Gene_or_gene_product"	"IFI16	362	367	Gene_or_gene_product"	"[{""token"": ""IFI16"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""IFI16"", ""start_span"": 193, ""end_span"": 198, ""type"": ""Gene_or_gene_product""}, {""token"": ""TNF - alpha"", ""start_span"": 241, ""end_span"": 252, ""type"": ""Gene_or_gene_product""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 266, ""end_span"": 301, ""type"": ""Gene_or_gene_product""}, {""token"": ""ICAM - 1"", ""start_span"": 304, ""end_span"": 312, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD54"", ""start_span"": 316, ""end_span"": 320, ""type"": ""Gene_or_gene_product""}, {""token"": ""IFI16"", ""start_span"": 362, ""end_span"": 367, ""type"": ""Gene_or_gene_product""}]"
These results suggest that CSC contribute to tumor angiogenesis by promoting both local endothelial cell activity and systemic angiogenic processes involving bone marrow - derived EPC in a vascular endothelial growth factor - dependent and stromal - derived factor 1 - dependent manner.	"CSC	27	30	Cell"	"tumor	45	50	Cancer"	"endothelial cell	88	104	Cell"	"bone marrow	158	169	Multi"	"EPC	180	183	Cell"	"vascular endothelial growth factor	189	223	Gene_or_gene_product"	"stromal - derived factor 1	240	266	Gene_or_gene_product"	"[{""token"": ""CSC"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Cancer""}, {""token"": ""endothelial cell"", ""start_span"": 88, ""end_span"": 104, ""type"": ""Cell""}, {""token"": ""bone marrow"", ""start_span"": 158, ""end_span"": 169, ""type"": ""Multi""}, {""token"": ""EPC"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Cell""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 189, ""end_span"": 223, ""type"": ""Gene_or_gene_product""}, {""token"": ""stromal - derived factor 1"", ""start_span"": 240, ""end_span"": 266, ""type"": ""Gene_or_gene_product""}]"
METHODS: We assessed the role of CDC4 / FBXW7 in gastric cancer, through loss of heterozygosity ( LOH) and multiplex ligation - dependent probe amplification ( MLPA) on 47 flow - sorted gastric carcinomas including early - onset gastric cancers ( EOGC) and xenografted conventional gastric carcinomas.	"CDC4	33	37	Gene_or_gene_product"	"FBXW7	40	45	Gene_or_gene_product"	"gastric cancer	49	63	Cancer"	"gastric carcinomas	186	204	Cancer"	"early - onset gastric cancers	215	244	Cancer"	"EOGC	247	251	Cancer"	"gastric carcinomas	282	300	Cancer"	"[{""token"": ""CDC4"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBXW7"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric cancer"", ""start_span"": 49, ""end_span"": 63, ""type"": ""Cancer""}, {""token"": ""gastric carcinomas"", ""start_span"": 186, ""end_span"": 204, ""type"": ""Cancer""}, {""token"": ""early - onset gastric cancers"", ""start_span"": 215, ""end_span"": 244, ""type"": ""Cancer""}, {""token"": ""EOGC"", ""start_span"": 247, ""end_span"": 251, ""type"": ""Cancer""}, {""token"": ""gastric carcinomas"", ""start_span"": 282, ""end_span"": 300, ""type"": ""Cancer""}]"
CONCLUSION: Loss of CDC4 / FBXW7 appears to play a role in both EOGC and conventional gastric carcinogenesis, and c - myc overexpression is likely to be an important oncogenic consequence of CDC4 / FBXW7 loss.	"CDC4	20	24	Gene_or_gene_product"	"FBXW7	27	32	Gene_or_gene_product"	"EOGC	64	68	Cancer"	"gastric	86	93	Organ"	"c - myc	114	121	Gene_or_gene_product"	"CDC4	191	195	Gene_or_gene_product"	"FBXW7	198	203	Gene_or_gene_product"	"[{""token"": ""CDC4"", ""start_span"": 20, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBXW7"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""EOGC"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Cancer""}, {""token"": ""gastric"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Organ""}, {""token"": ""c - myc"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""CDC4"", ""start_span"": 191, ""end_span"": 195, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBXW7"", ""start_span"": 198, ""end_span"": 203, ""type"": ""Gene_or_gene_product""}]"
Our initial investigations show that the naturally occurring organoselenium compound selenomethionine ( SM) and the synthetic 1, 4 - phenylenebis ( methylene) selenocyanate ( p - XSC) can inhibit human prostate cancer cell viability; however, in contrast to SM, p - XSC is active at physiologically relevant doses.	"selenomethionine	85	101	Chemical"	"SM	104	106	Chemical"	"p - XSC	175	182	Chemical"	"human	196	201	Organism"	"prostate cancer cell	202	222	Cell"	"SM	258	260	Chemical"	"p - XSC	262	269	Chemical"	"[{""token"": ""selenomethionine"", ""start_span"": 85, ""end_span"": 101, ""type"": ""Chemical""}, {""token"": ""SM"", ""start_span"": 104, ""end_span"": 106, ""type"": ""Chemical""}, {""token"": ""p - XSC"", ""start_span"": 175, ""end_span"": 182, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 196, ""end_span"": 201, ""type"": ""Organism""}, {""token"": ""prostate cancer cell"", ""start_span"": 202, ""end_span"": 222, ""type"": ""Cell""}, {""token"": ""SM"", ""start_span"": 258, ""end_span"": 260, ""type"": ""Chemical""}, {""token"": ""p - XSC"", ""start_span"": 262, ""end_span"": 269, ""type"": ""Chemical""}]"
Inhibition of Akt, however, does not fully attenuate p - XSC - mediated downregulation of AR activity, suggesting that inhibition of AR signaling by p - XSC does not occur solely through alterations in the phosphatidylinositol 3 - kinase / Akt survival pathway.	"Akt	14	17	Gene_or_gene_product"	"p - XSC	53	60	Chemical"	"AR	90	92	Gene_or_gene_product"	"AR	133	135	Gene_or_gene_product"	"p - XSC	149	156	Chemical"	"phosphatidylinositol 3 - kinase	206	237	Gene_or_gene_product"	"Akt	240	243	Gene_or_gene_product"	"[{""token"": ""Akt"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""p - XSC"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""AR"", ""start_span"": 90, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""AR"", ""start_span"": 133, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""p - XSC"", ""start_span"": 149, ""end_span"": 156, ""type"": ""Chemical""}, {""token"": ""phosphatidylinositol 3 - kinase"", ""start_span"": 206, ""end_span"": 237, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 240, ""end_span"": 243, ""type"": ""Gene_or_gene_product""}]"
By interacting with Sp1, HMGA2 interferes with the recruitment of HDAC2 to the hTERT proximal promoter, enhancing localized histone H3 - K9 acetylation and thereby stimulating hTERT expression and telomerase activity.	"Sp1	20	23	Gene_or_gene_product"	"HMGA2	25	30	Gene_or_gene_product"	"HDAC2	66	71	Gene_or_gene_product"	"hTERT	79	84	Gene_or_gene_product"	"histone H3	124	134	Gene_or_gene_product"	"hTERT	176	181	Gene_or_gene_product"	"telomerase	197	207	Gene_or_gene_product"	"[{""token"": ""Sp1"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""HMGA2"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""HDAC2"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""hTERT"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""histone H3"", ""start_span"": 124, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""hTERT"", ""start_span"": 176, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}, {""token"": ""telomerase"", ""start_span"": 197, ""end_span"": 207, ""type"": ""Gene_or_gene_product""}]"
This study investigated the expression of TS and DPD in cervical lymph node metastases and its relationship with primary OSCC, as well as the interaction between these enzymes and Kangai 1 ( KAI1 / CD82) which is a metastasis suppressor protein.	"TS	42	44	Gene_or_gene_product"	"DPD	49	52	Gene_or_gene_product"	"cervical lymph node	56	75	Multi"	"primary OSCC	113	125	Cancer"	"Kangai 1	180	188	Gene_or_gene_product"	"KAI1	191	195	Gene_or_gene_product"	"CD82	198	202	Gene_or_gene_product"	"[{""token"": ""TS"", ""start_span"": 42, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""DPD"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""cervical lymph node"", ""start_span"": 56, ""end_span"": 75, ""type"": ""Multi""}, {""token"": ""primary OSCC"", ""start_span"": 113, ""end_span"": 125, ""type"": ""Cancer""}, {""token"": ""Kangai 1"", ""start_span"": 180, ""end_span"": 188, ""type"": ""Gene_or_gene_product""}, {""token"": ""KAI1"", ""start_span"": 191, ""end_span"": 195, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD82"", ""start_span"": 198, ""end_span"": 202, ""type"": ""Gene_or_gene_product""}]"
Therefore, our results indicate that emodin inhibits HER - 2 / neu tyrosine kinase activity and preferentially suppresses growth and induces differentiation of HER - 2 / neu - overexpressing cancer cells.	"emodin	37	43	Chemical"	"HER - 2	53	60	Gene_or_gene_product"	"neu	63	66	Gene_or_gene_product"	"tyrosine	67	75	Amino_acid"	"HER - 2	160	167	Gene_or_gene_product"	"neu	170	173	Gene_or_gene_product"	"cancer cells	191	203	Cell"	"[{""token"": ""emodin"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Chemical""}, {""token"": ""HER - 2"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""tyrosine"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Amino_acid""}, {""token"": ""HER - 2"", ""start_span"": 160, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 170, ""end_span"": 173, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cells"", ""start_span"": 191, ""end_span"": 203, ""type"": ""Cell""}]"
This study was designed to evaluate the potential implication of stromelysin - 3 ( ST3), a newly identified member of the matrix - degrading metalloproteinase family, and of BM - 40 / SPARC, a glycoprotein associated with the extracellular matrix, during the progression of human colorectal cancers.	"stromelysin - 3	65	80	Gene_or_gene_product"	"ST3	83	86	Gene_or_gene_product"	"BM - 40	174	181	Gene_or_gene_product"	"SPARC	184	189	Gene_or_gene_product"	"extracellular matrix	226	246	Cellular_component"	"human	274	279	Organism"	"colorectal cancers	280	298	Cancer"	"[{""token"": ""stromelysin - 3"", ""start_span"": 65, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""ST3"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""BM - 40"", ""start_span"": 174, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}, {""token"": ""SPARC"", ""start_span"": 184, ""end_span"": 189, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular matrix"", ""start_span"": 226, ""end_span"": 246, ""type"": ""Cellular_component""}, {""token"": ""human"", ""start_span"": 274, ""end_span"": 279, ""type"": ""Organism""}, {""token"": ""colorectal cancers"", ""start_span"": 280, ""end_span"": 298, ""type"": ""Cancer""}]"
We analyzed the relative abundance of ST3 and BM - 40 / SPARC transcripts by Northern blot, and their distribution by in situ hybridization, in normal mucosa, benign adenomas, and primary colorectal adenocarcinomas and their liver metastases.	"ST3	38	41	Gene_or_gene_product"	"BM - 40	46	53	Gene_or_gene_product"	"SPARC	56	61	Gene_or_gene_product"	"mucosa	151	157	Multi"	"benign adenomas	159	174	Pathological_formation"	"colorectal adenocarcinomas	188	214	Cancer"	"liver	225	230	Organ"	"[{""token"": ""ST3"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""BM - 40"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""SPARC"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""mucosa"", ""start_span"": 151, ""end_span"": 157, ""type"": ""Multi""}, {""token"": ""benign adenomas"", ""start_span"": 159, ""end_span"": 174, ""type"": ""Pathological_formation""}, {""token"": ""colorectal adenocarcinomas"", ""start_span"": 188, ""end_span"": 214, ""type"": ""Cancer""}, {""token"": ""liver"", ""start_span"": 225, ""end_span"": 230, ""type"": ""Organ""}]"
No [ 13C] glucose utilization was detected in H4 spheroids, but uptake of alanine and accumulation of labeled lactate, glutamate and glutamine indicated oxidation via the tricarboxylic acid ( TCA) cycle.	"H4 spheroids	46	58	Cell"	"alanine	74	81	Amino_acid"	"lactate	110	117	Chemical"	"glutamate	119	128	Amino_acid"	"glutamine	133	142	Amino_acid"	"tricarboxylic acid	171	189	Chemical"	"TCA	192	195	Chemical"	"[{""token"": ""H4 spheroids"", ""start_span"": 46, ""end_span"": 58, ""type"": ""Cell""}, {""token"": ""alanine"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Amino_acid""}, {""token"": ""lactate"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Chemical""}, {""token"": ""glutamate"", ""start_span"": 119, ""end_span"": 128, ""type"": ""Amino_acid""}, {""token"": ""glutamine"", ""start_span"": 133, ""end_span"": 142, ""type"": ""Amino_acid""}, {""token"": ""tricarboxylic acid"", ""start_span"": 171, ""end_span"": 189, ""type"": ""Chemical""}, {""token"": ""TCA"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Chemical""}]"
Human cytomegalovirus ( HCMV), like other DNA tumor viruses, induces morphological transformation of cells in vitro and stimulates host cell macromolecular synthesis in infected cells.	"Human cytomegalovirus	0	21	Organism"	"HCMV	24	28	Organism"	"DNA	42	45	Cellular_component"	"tumor	46	51	Cancer"	"cells	101	106	Cell"	"cell	136	140	Cell"	"cells	178	183	Cell"	"[{""token"": ""Human cytomegalovirus"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Organism""}, {""token"": ""HCMV"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Organism""}, {""token"": ""DNA"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Cellular_component""}, {""token"": ""tumor"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Cancer""}, {""token"": ""cells"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 178, ""end_span"": 183, ""type"": ""Cell""}]"
Vascular and neoplastic tissue from 14 colonic adenocarcinomas, 13 carcinoids, 6 renal - cell carcinomas and 7 malignant lymphomas were analyzed for somatostatin receptors by use of quantitative receptor autoradiography.	"Vascular	0	8	Tissue"	"neoplastic tissue	13	30	Tissue"	"colonic adenocarcinomas	39	62	Cancer"	"carcinoids	67	77	Cancer"	"renal - cell carcinomas	81	104	Cancer"	"malignant lymphomas	111	130	Cancer"	"somatostatin receptors	149	171	Gene_or_gene_product"	"[{""token"": ""Vascular"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Tissue""}, {""token"": ""neoplastic tissue"", ""start_span"": 13, ""end_span"": 30, ""type"": ""Tissue""}, {""token"": ""colonic adenocarcinomas"", ""start_span"": 39, ""end_span"": 62, ""type"": ""Cancer""}, {""token"": ""carcinoids"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Cancer""}, {""token"": ""renal - cell carcinomas"", ""start_span"": 81, ""end_span"": 104, ""type"": ""Cancer""}, {""token"": ""malignant lymphomas"", ""start_span"": 111, ""end_span"": 130, ""type"": ""Cancer""}, {""token"": ""somatostatin receptors"", ""start_span"": 149, ""end_span"": 171, ""type"": ""Gene_or_gene_product""}]"
The results suggest that somatostatin and somatostatin receptors may play a regulatory role for hemodynamic tumor - host interactions, possibly involving tumor stroma generation, tumor environment, angiogenesis and, particularly, vascular drainage of poorly differentiated neoplasms.	"somatostatin	25	37	Gene_or_gene_product"	"somatostatin receptors	42	64	Gene_or_gene_product"	"tumor	108	113	Cancer"	"tumor stroma	154	166	Tissue"	"tumor	179	184	Cancer"	"vascular	230	238	Multi"	"neoplasms	273	282	Cancer"	"[{""token"": ""somatostatin"", ""start_span"": 25, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""somatostatin receptors"", ""start_span"": 42, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 108, ""end_span"": 113, ""type"": ""Cancer""}, {""token"": ""tumor stroma"", ""start_span"": 154, ""end_span"": 166, ""type"": ""Tissue""}, {""token"": ""tumor"", ""start_span"": 179, ""end_span"": 184, ""type"": ""Cancer""}, {""token"": ""vascular"", ""start_span"": 230, ""end_span"": 238, ""type"": ""Multi""}, {""token"": ""neoplasms"", ""start_span"": 273, ""end_span"": 282, ""type"": ""Cancer""}]"
In order to better understand the coordinated regulation of cell - cell and cell - matrix interactions during malignant transformation, we have studied the expression of syndecan - 1 in malignant mammary tumor cells genetically manipulated for E - cadherin expression.	"cell	60	64	Cell"	"cell	67	71	Cell"	"cell	76	80	Cell"	"matrix	83	89	Cellular_component"	"syndecan - 1	170	182	Gene_or_gene_product"	"malignant mammary tumor cells	186	215	Cell"	"E - cadherin	244	256	Gene_or_gene_product"	"[{""token"": ""cell"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""matrix"", ""start_span"": 83, ""end_span"": 89, ""type"": ""Cellular_component""}, {""token"": ""syndecan - 1"", ""start_span"": 170, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignant mammary tumor cells"", ""start_span"": 186, ""end_span"": 215, ""type"": ""Cell""}, {""token"": ""E - cadherin"", ""start_span"": 244, ""end_span"": 256, ""type"": ""Gene_or_gene_product""}]"
